Skip to main content

GOLDMAN SACHS GROUP INC

Position in OGN — Organon & Co.

CIK 886982 NEW YORK, NY

Position in OGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$70,394,486
+$60,778,590 QoQ
Shares Held
5,199,002
+223.9% QoQ
Ownership
1.98%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#6
of 626 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in OGN Over Time

Shares Held

Position Value (USD)

Derivatives in OGN

reported options exposure · as of Dec 31, 2022
CallValue
$0
CallShares
0
PutValue
$279,300
PutShares
10,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $29,799,350,964 across 16 Drug Manufacturers - General names. OGN ranks #15 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in OGN

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $70,394,486 5,199,002
2026-03-31 $9,615,896 1,605,325
2025-12-31 $13,484,009 1,880,615
2025-09-30 $17,693,149 1,656,662
2025-06-30 $18,263,168 1,886,691
2025-03-31 $21,370,097 1,435,198
2024-12-31 $9,457,651 633,891
2024-09-30 $11,755,211 614,491
2024-06-30 $18,941,595 915,053
2024-03-31 $10,366,751 551,423
2023-12-31 $6,052,894 419,757
2023-09-30 $26,186,429 1,508,435
2023-06-30 $45,583,950 2,190,483
2023-03-31 $17,328,476 736,755
2022-12-31 $10,199,700 365,188
2022-12-31 $279,300 10,000
2022-09-30 $234,000 10,000
2022-09-30 $13,958,122 596,501
2022-06-30 $337,500 10,000
2022-06-30 $17,894,316 530,202
2022-03-31 $349,300 10,000
2022-03-31 $40,753,669 1,166,724
2021-12-31 $844,987 27,750
2021-12-31 $23,084,327 758,106
2021-09-30 $909,922 27,750
2021-09-30 $41,870,991 1,276,944
2021-06-30 $917,483 30,320
2021-06-30 $37,687,286 1,245,449